E
Optiva Inc. OPT.TO
TSX
Recommendation
Prev Close
$1.92
Volume
--
Avg Vol (90D)
2,065
Market Cap
$8.59M
Dividend & Yield
--
52-Week Range
$1.23 - $9.13
P/E (TTM)
--
EPS (TTM)
-$3.18
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
opthea lays 65 staff after back back phase 3 flops
4/10/2025 - FierceBiotech.com - Biotech
Opthea Announces Major Workforce Reduction Following Trial Setbacks
4/10/2025 - TipRanks Financial Blog
Regal Asian Investments Updates NTA and Revalues Opthea Holding
4/7/2025 - TipRanks Financial Blog
VGI Partners Global Investments Ltd Announces NTA Update with Opthea Revaluation
4/7/2025 - TipRanks Financial Blog
Short Interest in Opthea Limited (NASDAQ:OPT) Expands By 20.7%
4/4/2025 - MarketBeat
Hedge Fund and Insider Trading News: George Soros, Steve Cohen, Ray Dalio, Israel Englander, Citadel Investment Group, Greenlight Capital, Petco Health and Wellness Company Inc (WOOF), Atlassian Corp (TEAM), and More
4/2/2025 - Insider Monkey
Hearts and Minds Investments Announces Opthea Write-Down
4/2/2025 - TipRanks Financial Blog
Opthea (OPT) Halts Key Trials Following Disappointing Results
3/31/2025 - GuruFocus
Opthea terminates COAST trial, announces ShORe trial misses endpoint
3/31/2025 - TipRanks Financial Blog
Opthea terminates COAST trial, announces ShORe trial misses endpoint
3/31/2025 - The Fly
Opthea announces decision to discontinue wet AMD trials
3/31/2025 - SeekingAlpha.com: All News
Opthea announces decision to discontinue wet AMD trials
3/31/2025 - Seeking Alpha - Healthcare
opthea scraps wet amd program after eye drug loses out lucentis phase 3
3/31/2025 - FierceBiotech.com - Biotech
Opthea Announces Decision to Discontinue Wet AMD Trials
3/31/2025 - GuruFocus
Opthea Announces Decision to Discontinue Wet AMD Trials
3/31/2025 - Globe Newswire
Opthea Limited's Securities Suspended Due to Financial Concerns
3/31/2025 - TipRanks Financial Blog
Opthea Halts Wet AMD Trials Following Unsuccessful Phase 3 Results
3/31/2025 - TipRanks Financial Blog
JPMorgan Chase Acquires Substantial Stake in Opthea Limited
3/30/2025 - TipRanks Financial Blog
Opthea (NASDAQ:OPT) Cut to Market Perform at Leerink Partners
3/28/2025 - Ticker Report
Opthea Limited (NASDAQ:OPT) Receives Consensus Rating of "Hold" from Brokerages
3/27/2025 - MarketBeat
Opthea (NASDAQ:OPT) Downgraded by Leerink Partnrs to Hold
3/27/2025 - MarketBeat
Opthea (NASDAQ:OPT) Downgraded to "Neutral" Rating by HC Wainwright
3/26/2025 - MarketBeat
Opthea (NASDAQ:OPT) Stock Rating Lowered by Leerink Partners
3/26/2025 - MarketBeat
Opthea's (OPT) Underperform Rating Reaffirmed at Jefferies Financial Group
3/26/2025 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)
3/26/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$47.08M
EBITDA (TTM)
-$6.97M
EBIT (TTM)
-$7.56M
Net Income (TTM)
-$19.68M
Balance Sheet
Total Assets (Q)
$70.14M
Total Debt (Q)
$102.70M
Total Liabilities (Q)
$126.88M
Book Value Per Share (Q)
-$18.26
Cash Flow
Cash from Operations (TTM)
$415.00K
Cash from Investing (TTM)
-$428.00K
Cash from Financing (TTM)
-$10.10M
Net Change in Cash (TTM)
-$9.43M
Filings
Filing Date
Tuesday, March 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
-0.37
7-Day Total Return
-25.00%
30-Day Total Return
-52.68%
60-Day Total Return
-74.14%
90-Day Total Return
-57.14%
Year to Date Total Return
-45.45%
1-Year Total Return
-75.04%
2-Year Total Return
-91.15%
3-Year Total Return
-93.18%
5-Year Total Return
-94.00%
52-week Low
Apr 04, 2025 - $1.23
52-week High
May 15, 2024 - $9.13
Valuation
Market Cap
$8.59M - Nano Cap
Enterprise Value
$104.46M
Price/Sales (TTM)
0.25
Price/Book (Q)
-0.11
Dividends and Shares
Shares Outstanding
6.21M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.optiva.com
Phone Number
905-625-2622
Address
2233 Argentia Rd
Mississauga, ON L5N 2X7
Country
Canada
Year Founded
1999
Business Description
Sector
Information Technology
Industry
Software and Services
Optiva Inc. provides cloud-native monetization and business support systems products to communication service providers (CSP) in Europe, the Middle East, Africa, North America, Latin America, the... more